The build-out of a comprehensive regulatory framework for payment stablecoins is steadily moving toward completion, as the various agencies ...
Stocktwits on MSN
MBRX stock drops 25% as Moleculin Biotech's interim cancer trial data falls short of significance
The company said the independent safety board reviewing the study saw a clear trend favoring the Annamycin combination, though there was no statistical significance. ・Full data from the first part of ...
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control ...
Close to a third of firms inspected by the Solicitors Regulation Authority (SRA) were found non-compliant. AMLCC’s Richard Simms explains what inspectors look for and how to ensure your firm is ready.
On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...
A confirmed letter of credit safeguards sellers' payments in international trade with bank guarantees. Discover how it works ...
The Treasury Department is guiding banks to share information on suspected undocumented customers, framing it as a crackdown on fraud and crime. New guidance allows banks to rapidly share data and ...
As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their ...
Cancer-associated myocarditis outside of immunotherapy: National burden and inpatient outcomes in the National Inpatient Sample, 2018–2023. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
Post-HSCT gilteritinib maintenance in R/R FLT3-mutated AML showed encouraging OS and relapse-free survival ranges, suggesting a possible survival advantage versus historical cohorts without ...
AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...
Cancer Res (2026) 86 (7_Supplement): 2495. Waiting for test results is a primary cause of delay in the diagnostic classification and risk stratification of patients with AML. With conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results